home / stock / amrn / amrn news

AMRN News and Press, Amarin Corporation plc From 02/24/26

Stock Information
Company Name: Amarin Corporation plc
Stock Symbol: AMRN
Market: NASDAQ
Website: amarincorp.com
Menu
Get AMRN Alerts

News, Short Squeeze, Breakout and More Instantly...
AMRN - Amarin Q4 2025 Earnings Preview

2026-02-24 10:08:28 ET More on Amarin Amarin expects full-year 2025 revenue in-line with estimates Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Amarin Read the full article on Seeking Al...
AMRN - Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026

DUBLIN and BRIDGEWATER, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced that it will report fourth quarter and full year 2025 financial results and conduct a conference call on Wedn...

AMRN - Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company's VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization

DUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on recent innovations in therapies for patients with elevated triglycerides (TG) and shared its perspect...

AMRN - Amarin expects full-year 2025 revenue in-line with estimates

2026-01-08 08:00:31 ET More on Amarin Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings Amarin NON-GAAP EPS of $0.01, revenue of ...
AMRN - Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities

DUBLIN and BRIDGEWATER, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced select preliminary unaudited 2025 financial highlights, provided a summary of key 2025 operational accomp...

AMRN - New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients

DUBLIN and BRIDGEWATER, N.J., Nov. 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that icosapent ethyl significantl...

AMRN - Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025

DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today announced it will be presenting new findings at the American Heart Association's Scientific Sessions 2025 scheduled for...
AMRN - Amarin outlines accelerated path to positive free cash flow in 2026 supported by Recordati partnership and $70M OpEx savings

2025-10-29 10:22:29 ET More on Amarin Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom Amarin NON-GAAP EPS of 0.19 revenue of $49.7M beats by $6.6M Amarin Q3 2025 Earnings Pr...

AMRN - Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript

2025-10-29 10:21:30 ET Amarin Corporation plc (AMRN) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: Amarin Corporation plc (AMRN) Q3 2025 Earnings Call Transcript

AMRN - Amarin GAAP EPS of -$0.02 beats by $0.41, revenue of $49.7M beats by $6.6M

2025-10-29 07:07:43 ET More on Amarin Amarin: Vascepa's Global Pivot From U.S. Squeeze To International Boom Amarin Q3 2025 Earnings Preview Seeking Alpha’s Quant Rating on Amarin Historical earnings data for Amarin Financial information for Am...
Previous 10 Next 10